Why is integrated treatment important for patients with both substance use disorder and major mood or anxiety disorders?

• A. It focuses only on substance use
• B. It coordinates pharmacotherapy and psychotherapy for both conditions, improving retention and abstinence
• C. It delays treatment until mood disorders resolve
• D. It uses only pharmacotherapy

Answer: (B)

When someone has both a substance use disorder and a mood or anxiety disorder, symptoms and triggers cross-maintain each condition. Integrated treatment addresses both problems in a single, coordinated plan, rather than tackling one and delaying or ignoring the other.

This approach coordinates pharmacotherapy and psychotherapy for both conditions. Medications are chosen and managed with awareness of how they affect mood, anxiety, cravings, and substance use, while therapy targets coping skills, relapse prevention, and mood regulation at the same time. Delivering evidence-based psychotherapies (like cognitive-behavioral strategies, motivational approaches, and contingency management) alongside addiction-focused care helps patients confront mood or anxiety symptoms without turning to substances, and it supports sustained abstinence.

The benefit shows up in real-world outcomes: patients are more likely to stay engaged in treatment and to achieve abstinence when care is integrated. Fragmented care—treating the mood/anxiety disorder separately or delaying its treatment—often leads to persistent symptoms, higher relapse risk, and limited progress because the driving factors for substance use (and the mood symptoms fueling them) aren’t being addressed together.

So, the best approach is a unified plan that treats both disorders concurrently with coordinated pharmacologic and psychotherapeutic strategies, offering the most comprehensive and effective path to recovery.